Jennison Associates LLC Tarsus Pharmaceuticals, Inc. Transaction History
Jennison Associates LLC
- $141 Billion
- Q1 2025
A detailed history of Jennison Associates LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 2,492,640 shares of TARS stock, worth $105 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,492,640
Previous 2,500,132
0.3%
Holding current value
$105 Million
Previous $138 Million
7.5%
% of portfolio
0.09%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding TARS
# of Institutions
201Shares Held
44.3MCall Options Held
19.9KPut Options Held
7.6K-
Rtw Investments, LP New York, NY3.32MShares$140 Million2.79% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$138 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.61MShares$110 Million6.87% of portfolio
-
Tang Capital Management LLC San Diego, CA2.45MShares$104 Million8.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.23MShares$93.9 Million0.0% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $1.12B
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...